Literature DB >> 17662160

Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study.

Constancio Medrano1, Luis Garcia-Guereta, Josefina Grueso, Beatriz Insa, Fernando Ballesteros, Jaume Casaldaliga, Victorio Cuenca, Fuensanta Escudero, Lola Garcia de la Calzada, Maite Luis, Manuel Luque, Alberto Mendoza, Fredy Prada, Maria del Mar Rodríguez, Pedro Suarez, Concepción Quero, Magda Guilera.   

Abstract

OBJECTIVES: To evaluate the rate of hospitalization for acute respiratory tract infection in children less than 24 months with haemodynamically significant congenital cardiac disease, and to describe associated risk factors, preventive measures, aetiology, and clinical course.
MATERIALS AND METHODS: We followed 760 subjects from October 2004 through April 2005 in an epidemiological, multicentric, observational, follow-up, prospective study involving 53 Spanish hospitals.
RESULTS: Of our cohort, 79 patients (10.4%, 95% CI: 8.2%-12.6%) required a total of 105 admissions to hospital related to respiratory infections. The incidence rate was 21.4 new admissions per 1000 patients-months. Significant associated risk factors for hospitalization included, with odds ratios and 95% confidence intervals shown in parentheses: 22q11 deletion (8.2, 2.5-26.3), weight below the 10th centile (5.2, 1.6-17.4), previous respiratory disease (4.5, 2.3-8.6), incomplete immunoprophylaxis against respiratory syncytial virus (2.2, 1.2-3.9), trisomy 21 (2.1, 1.1-4.2), cardiopulmonary bypass (2.0, 1.1-3.4), and siblings aged less than 11 years old (1.7, 1.1-2.9). Bronchiolitis (51.4%), upper respiratory tract infections (25.7%), and pneumonia (20%) were the main diagnoses. An infectious agent was found in 37 cases (35.2%): respiratory syncytial virus in 25, Streptococcus pneumoniae in 5, and Haemophilus influenzae in 4. The odds ratio for hospitalization due to infection by the respiratory syncytial virus increases by 3.05 (95% CI: 2.14 to 4.35) in patients with incomplete prophylaxis. The median length of hospitalization was 7 days. In 18 patients (17.1%), the clinical course of respiratory infection was complicated and 2 died.
CONCLUSIONS: Hospital admissions for respiratory infection in young children with haemodynamically significant congenital cardiac disease are mainly associated with non-cardiac conditions, which may be genetic, malnutrition, or respiratory, and to cardiopulmonary bypass. Respiratory syncytial virus was the most commonly identified infectious agent. Incomplete immunoprophylaxis against the virus increased the risk of hospitalization.

Entities:  

Mesh:

Year:  2007        PMID: 17662160     DOI: 10.1017/S104795110700042X

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  8 in total

1.  Ventilator-associated pneumonia in children after cardiac surgery.

Authors:  Ghassan A Shaath; Abdulraouf Jijeh; Fawaz Faruqui; Lily Bullard; Akhter Mehmood; Mohamed S Kabbani
Journal:  Pediatr Cardiol       Date:  2013-11-21       Impact factor: 1.655

2.  Performance of a Risk Analytic Tool (Index of Tissue Oxygen Delivery "IDO2") in Pediatric Cardiac Intensive Care Unit of a Developing Country.

Authors:  Qalab Abbas; Muhammad Zaid H Hussain; Fatima Farrukh Shahbaz; Naveed Ur Rehman Siddiqui; Babar S Hasan
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

3.  Risk factors for hospitalisation in Welsh infants with a congenital anomaly.

Authors:  Peter S Y Ho; Maria A Quigley; David F Tucker; Jennifer J Kurinczuk
Journal:  BMJ Paediatr Open       Date:  2022-02

4.  Pediatric emergency room presentation of congenital heart disease.

Authors:  Yun Sik Lee; Jae Suk Baek; Bo Sang Kwon; Gi Beom Kim; Eun Jung Bae; Chung Il Noh; Jung Yun Choi; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-01-27       Impact factor: 3.243

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

6.  The impact of congenital heart diseases on the quality of life of patients and their families in Saudi Arabia. Biological, psychological, and social dimensions.

Authors:  Ahmad S Azhar; Zahra H AlShammasi; Rawan E Higgi
Journal:  Saudi Med J       Date:  2016-04       Impact factor: 1.484

Review 7.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.

Authors:  Paul A Checchia; Bosco Paes; Louis Bont; Paolo Manzoni; Eric A F Simões; Brigitte Fauroux; Josep Figueras-Aloy; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2017-01-09

8.  Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India.

Authors:  Sakshi Sachdeva; Sivasubramanian Ramakrishnan; Mrigank Choubey; Nageswara Rao Koneti; Kalaivani Mani; Shweta Bakhru; Saurabh Kumar Gupta; Debasree Gangopadhyay; Soumya Kasturi; Jayashree Mishra; Hemant Kumar Nayak; Kothandam Sivakumar; Prashant Bobhate; Neeraj Awasthy; Debasis Das; Manisha Chakrabarti; Chinnaswamy Sivaprakasam Muthukumaran; Rajan Saileela; Bhargavi Dhulipudi; Shiv Kumar Chaudhary; Mahimarangaiah Jayranganath; Anita Saxena; Krishna Subramony Iyer; Raman Krishna Kumar; Shyam S Kothari; Snehal Kulkarni; Suresh G Rao
Journal:  Ann Pediatr Cardiol       Date:  2021-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.